- Home
- AUTL vs VREX Comparison
AUTL vs VREX Comparison
Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- VREX
- Stock Information
- Founded
- AUTL 2014
- VREX 2016
- Country
- AUTL United Kingdom
- VREX United States
- Employees
- AUTL N/A
- VREX 2300
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- VREX Industrial Machinery/Components
- Sector
- AUTL Health Care
- VREX Technology
- Exchange
- AUTL Nasdaq
- VREX Nasdaq
- Market Cap
- AUTL 590.8M
- VREX 576.8M
- IPO Year
- AUTL 2018
- VREX N/A
- Fundamental
- Price
- AUTL $2.17
- VREX $14.15
- Analyst Decision
- AUTL Strong Buy
- VREX Strong Buy
- Analyst Count
- AUTL 3
- VREX 1
- Target Price
- AUTL $10.20
- VREX $21.00
- AVG Volume (30 Days)
- AUTL 1.1M
- VREX 377.8K
- Earning Date
- AUTL 03-13-2025
- VREX 02-06-2025
- Dividend Yield
- AUTL N/A
- VREX N/A
- EPS Growth
- AUTL N/A
- VREX N/A
- EPS
- AUTL N/A
- VREX N/A
- Revenue
- AUTL $10,091,000.00
- VREX $811,000,000.00
- Revenue This Year
- AUTL $851.83
- VREX $3.50
- Revenue Next Year
- AUTL $224.65
- VREX $3.37
- P/E Ratio
- AUTL N/A
- VREX N/A
- Revenue Growth
- AUTL 82.71
- VREX N/A
- 52 Week Low
- AUTL $2.07
- VREX $10.19
- 52 Week High
- AUTL $7.37
- VREX $19.91
- Technical
- Relative Strength Index (RSI)
- AUTL 41.81
- VREX 43.34
- Support Level
- AUTL $2.11
- VREX $13.35
- Resistance Level
- AUTL $2.26
- VREX $14.08
- Average True Range (ATR)
- AUTL 0.12
- VREX 0.41
- MACD
- AUTL 0.01
- VREX 0.03
- Stochastic Oscillator
- AUTL 27.78
- VREX 23.89
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.